Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials

From MaRDI portal
Publication:3079146


DOI10.1111/1541-0420.00063zbMath1210.62161WikidataQ30336405 ScholiaQ30336405MaRDI QIDQ3079146

Michael G. Hudgens, Ronald J. Bosch, Peter B. Gilbert

Publication date: 1 March 2011

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://biostats.bepress.com/cgi/viewcontent.cgi?article=1031&context=uwbiostat


62P10: Applications of statistics to biology and medical sciences; meta analysis

92C50: Medical applications (general)

62N03: Testing in survival analysis and censored data


Related Items

Assessing Treatment‐Selection Markers using a Potential Outcomes Framework, Partially Hidden Markov Model for Time-Varying Principal Stratification in HIV Prevention Trials, Impact of Multiple Matched Controls on Design Sensitivity in Observational Studies, Estimation of attributable fractions using inverse probability weighting, Weighted M-statistics With Superior Design Sensitivity in Matched Observational Studies With Multiple Controls, Optimal Tradeoffs in Matched Designs Comparing US-Trained and Internationally Trained Surgeons, The Blessings of Multiple Causes, Rejoinder, Augmented Designs to Assess Immune Response in Vaccine Trials, Sharpening Bounds on Principal Effects with Covariates, Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis, Designs in partially controlled studies: messages from a review, What can Statistics Contribute to a Causal Understanding?, Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis, Designs in partially controlled studies: messages from a review, Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials, Polydesigns and Causal Inference, A Potential Outcomes Approach to Developmental Toxicity Analyses, Reinforced Designs: Multiple Instruments Plus Control Groups as Evidence Factors in an Observational Study of the Effectiveness of Catholic Schools, Sensitivity analysis for stratified comparisons in an observational study of the effect of smoking on homocysteine levels, Chop-Lump Tests for Vaccine Trials, Nonparametric bounds and sensitivity analysis of treatment effects, Interference and sensitivity analysis, Defining and estimating intervention effects for groups that will develop an auxiliary outcome, On the estimation of a binary response model in a selected population, The potential for bias in principal causal effect estimation when treatment received depends on a key covariate, Assessment of the extent of corroboration of an elaborate theory of a causal hypothesis using partial conjunctions of evidence factors, Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption, An exact adaptive test with superior design sensitivity in an observational study of treatments for ovarian cancer, Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model, Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials, Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity, Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data, A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections, Sensitivity Analysis for Principal Stratum Direct Effects, with an Application to a Study of Physical Activity and Coronary Heart Disease



Cites Work